M. Boulassel

Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopes.

J. Routy, F. Dufour, D. Leclerc, 2010, Vaccine.

Expression of Integrin Type 1 Infection Regardless of Their Preferential Targets for Productive HIV T Cells Are + CD 4 + Memory CCR 6 and

J. Routy, N. Grandvaux, A. Gosselin, 2011 .

The Effect of β-Carotene Supplementation on the Pharmacokinetics of Nelfinavir and Its Active Metabolite M8 in HIV-1-infected Patients

Neeraj Singhal, N. Sheehan, R. Lalonde, 2012, Molecules.

Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection.

J. Routy, R. Cheynier, R. Sékaly, 2007, Blood.

recovery are associated with efficient thymopoiesis during HIV-1 infection Slow disease progression and robust therapy-mediated CD4+ T-cell

J. Routy, R. Cheynier, R. Sékaly, 2013 .

Influence of RANTES, SDF‐1 and TGF‐β levels on the value of interleukin‐7 as a predictor of virological response in HIV‐1‐infected patients receiving double boosted protease inhibitor‐based therapy

M. Klein, R. Leblanc, M. Boulassel, 2005, HIV medicine.

Changes in immunological and virological parameters in HIV‐1 infected subjects following leukapheresis

C. Tremblay, D. Rouleau, R. Sékaly, 2003, Journal of clinical apheresis.